GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Epitomee Medical Ltd (XTAE:EPIT) » Definitions » COGS-to-Revenue

Epitomee Medical (XTAE:EPIT) COGS-to-Revenue : 0.00 (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Epitomee Medical COGS-to-Revenue?

Epitomee Medical's Cost of Goods Sold for the six months ended in Jun. 2024 was ₪0.00 Mil. Its Revenue for the six months ended in Jun. 2024 was ₪0.00 Mil.

Epitomee Medical's COGS to Revenue for the six months ended in Jun. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Epitomee Medical's Gross Margin % for the six months ended in Jun. 2024 was N/A%.


Epitomee Medical COGS-to-Revenue Historical Data

The historical data trend for Epitomee Medical's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Epitomee Medical COGS-to-Revenue Chart

Epitomee Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial - - - - -

Epitomee Medical Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Epitomee Medical COGS-to-Revenue Calculation

Epitomee Medical's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 37.498
=0.00

Epitomee Medical's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Epitomee Medical  (XTAE:EPIT) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Epitomee Medical's Gross Margin % for the six months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Epitomee Medical COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Epitomee Medical's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Epitomee Medical Business Description

Traded in Other Exchanges
N/A
Address
Tarshish 19, Caesarea, ISR, 3088900
Epitomee Medical Ltd is engaged in developing and commercializing ingestible therapeutic devices.

Epitomee Medical Headlines

No Headlines